Patheon has successfully released the first commercial shipments of Zogenix‘s Sumavel DosePro (sumatriptan injection), in anticipation of the product’s U.S. commercial product launch scheduled in January 2010. The successful production of this new, needle-free drug product/delivery system is the culmination of joint manufacturing process and equipment development between the two companies, according to a Patheon statement. “We are excited to have shipped this initial commer...